Sign in with Google. Opens in new tab
bullish
China Biologic Products - Great Track Record Should Help to Digest the Large Deal
279 Views02 Mar 2016 04:20
Warburg Pincus plans to raise approximately US$370m though a partial sale of its stake in China Biological Products (CBPO). The deal scores a...
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 5-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- Saint Bella IPO (2508.HK): Pricing and Post-IPO Performance, Wild Price Swings Could Be Short-Lived
- Merger Arb Mondays (30 June) - Toyota Industries, Santos, Pointsbet, Dickson, HKBN, OneConnect
- Anjoy Foods Group HK Offer: Value Stock or Value Trap? Key Facts, Financials and Valuation
- FWD Group Holdings (1828 HK): Low Free Float Delays and Limits Global Index Inclusion
- A/H Premium Tracker (To 27 June 2025): "Beautiful Skew" Continues as SB Buys, AH Premia Fall Back
Top Unpaywalled Insights
More »- [IO Technicals 2025/26] Bearish Momentum Intensifies
- "The Data Bottleneck in Quant Finance — and How to Break It" With David Forino, CTO of Quanted
- The New OS for Quant Finance: OpenBB, AI Agents & the Death of Legacy Terminals | New Barbarians ...
- Curator's Cut: Building Materials Moves, Benchmarking Gold Miners & Semaglutide in India and Japan
- Overview# 29- The Hard-Asset Reset: Buying the Pullback in Commodities
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- China's Healthcare Reform Consolidates Drug Distribution and Cuts Manufacturer Margins05 Sep 2017
- China Biologic Products - Great Track Record Should Help to Digest the Large Deal02 Mar 2016
x